Malik JA, Ahmed S, Mir A, Shinde M, Bender O, Alshammari F et al (2022) The SARS-CoV-2 mutations versus vaccine effectiveness: new opportunities to new challenges. J Infect Public Health 15(2):228–240
Article PubMed PubMed Central Google Scholar
D’Arena G, Penna A, Crocamo A, Sguazzo F, Viceconti R, Barlotti V et al (2021) Heterogeneity of clinical and radiological findings of COVID-19. Postgrad Med J 97(1146):268–269
Al Maqbali M, Al Badi K, Al Sinani M, Madkhali N, Dickens GL (2022) Clinical Features of COVID-19 patients in the first year of pandemic: a systematic review and meta-analysis. Biol Res Nurs 24(2):172–185
Article CAS PubMed Google Scholar
El-Shabasy RM, Nayel MA, Taher MM, Abdelmonem R, Shoueir KR, Kenawy ER (2022) Three waves changes, new variant strains, and vaccination effect against COVID-19 pandemic. Int J Biol Macromol 204:161–168
Article CAS PubMed PubMed Central Google Scholar
Geng J, Yu X, Bao H, Feng Z, Yuan X, Zhang J et al (2021) Chronic diseases as a predictor for severity and mortality of COVID-19: a systematic review with cumulative meta-analysis. Front Med (Lausanne) 8:588013
Galbadage T, Peterson BM, Awada J, Buck AS, Ramirez DA, Wilson J et al (2020) Systematic review and meta-analysis of sex-specific COVID-19 clinical outcomes. Front Med (Lausanne) 7:348
Rastrelli G, Di Stasi V, Inglese F, Beccaria M, Garuti M, Di Costanzo D et al (2021) Low testosterone levels predict clinical adverse outcomes in SARS-CoV-2 pneumonia patients. Andrology 9(1):88–98
Article CAS PubMed Google Scholar
Vena W, Pizzocaro A, Maida G, Amer M, Voza A, Di Pasquale A et al (2022) Low testosterone predicts hypoxemic respiratory insufficiency and mortality in patients with COVID-19 disease: another piece in the COVID puzzle. J Endocrinol Invest 45(4):753–762
Article CAS PubMed Google Scholar
Corona G, Vena W, Pizzocaro A, Pallotti F, Paoli D, Rastrelli G, et al (2022) Andrological effects of SARS-Cov-2 infection: a systematic review and meta-analysis. J Endocrinol Invest. https://doi.org/10.1007/s40618-022-01801-x
Di Stasi V, Rastrelli G, Inglese F, Beccaria M, Garuti M, Di Costanzo D et al (2022) Higher testosterone is associated with increased inflammatory markers in women with SARS-CoV-2 pneumonia: preliminary results from an observational study. J Endocrinol Invest 45(3):639–648
Ware LB, Matthay MA (2000) The acute respiratory distress syndrome. N Engl J Med 342(18):1334–1349
Article CAS PubMed Google Scholar
Friedewald WT, Levy RI, Fredrickson DS (1972) Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge. Clin Chem 18(6):499–502
Article CAS PubMed Google Scholar
Dittadi R, Matteucci M, Meneghetti E, Ndreu R (2018) Reassessment of the Access Testosterone chemiluminescence assay and comparison with LC-MS method. J Clin Lab Anal. 32(3)
Evans JD (1996) Straightforward Statistics for the Behavioral Sciences: Brooks/Cole Publishing Company
Pavlou M, Ambler G, Seaman SR, Guttmann O, Elliott P, King M et al (2015) How to develop a more accurate risk prediction model when there are few events. BMJ British Med J 351:h3868
Subramanian A, Anand A, Adderley NJ, Okoth K, Toulis KA, Gokhale K et al (2021) Increased COVID-19 infections in women with polycystic ovary syndrome: a population-based study. Eur J Endocrinol 184(5):637–645
Article CAS PubMed PubMed Central Google Scholar
de Medeiros SF, Yamamoto MMW, de Medeiros MAS, Yamamoto A, Barbosa BB (2022) Polycystic ovary syndrome and risks for COVID-19 infection: a comprehensive review: PCOS and COVID-19 relationship. Rev Endocr Metab Disord 23(2):251–264
Article PubMed PubMed Central Google Scholar
González F (2012) Inflammation in Polycystic Ovary Syndrome: underpinning of insulin resistance and ovarian dysfunction. Steroids 77(4):300–305
Glintborg D, Rubin KH, Nybo M, Abrahamsen B, Andersen M (2018) Cardiovascular disease in a nationwide population of Danish women with polycystic ovary syndrome. Cardiovasc Diabetol 17(1):37
Article CAS PubMed PubMed Central Google Scholar
Glueck CJ, Goldenberg N (2019) Characteristics of obesity in polycystic ovary syndrome: Etiology, treatment, and genetics. Metabolism 92:108–120
Article CAS PubMed Google Scholar
O’Reilly MW, Glisic M, Kumarendran B, Subramanian A, Manolopoulos KN, Tahrani AA et al (2019) Serum testosterone, sex hormone-binding globulin and sex-specific risk of incident type 2 diabetes in a retrospective primary care cohort. Clin Endocrinol (Oxf) 90(1):145–154
Article CAS PubMed Google Scholar
Kumarendran B, O’Reilly MW, Manolopoulos KN, Toulis KA, Gokhale KM, Sitch AJ et al (2018) Polycystic ovary syndrome, androgen excess, and the risk of nonalcoholic fatty liver disease in women: a longitudinal study based on a United Kingdom primary care database. PLoS Med 15(3):e1002542
Article PubMed PubMed Central Google Scholar
Cadegiani FA, Lim RK, Goren A, McCoy J, Situm M, Kovacevic M et al (2021) Clinical symptoms of hyperandrogenic women diagnosed with COVID-19. J Eur Acad Dermatol Venereol 35(2):e101–e104
Article CAS PubMed Google Scholar
Baratchian M, McManus JM, Berk MP, Nakamura F, Mukhopadhyay S, Xu W et al (2021) Androgen regulation of pulmonary AR, TMPRSS2 and ACE2 with implications for sex-discordant COVID-19 outcomes. Sci Rep 11(1):11130
Article CAS PubMed PubMed Central Google Scholar
Mohamed MS, Moulin TC, Schiöth HB (2021) Sex differences in COVID-19: the role of androgens in disease severity and progression. Endocrine 71(1):3–8
Article CAS PubMed Google Scholar
Sansone A, Mollaioli D, Ciocca G, Limoncin E, Colonnello E, Vena W et al (2021) Addressing male sexual and reproductive health in the wake of COVID-19 outbreak. J Endocrinol Invest 44(2):223–231
Article CAS PubMed Google Scholar
Sex TV, Response HDI (2018) Front Immunol 9:1931
Kalinchenko SY, Tishova YA, Mskhalaya GJ, Gooren LJ, Giltay EJ, Saad F (2010) Effects of testosterone supplementation on markers of the metabolic syndrome and inflammation in hypogonadal men with the metabolic syndrome: the double-blinded placebo-controlled Moscow study. Clin Endocrinol (Oxf) 73(5):602–612
Article CAS PubMed Google Scholar
Corona G, Rastrelli G, Vignozzi L, Mannucci E, Maggi M (2011) Testosterone, cardiovascular disease and the metabolic syndrome. Best Pract Res Clin Endocrinol Metab 25(2):337–353
Article CAS PubMed Google Scholar
Lania A, Sandri MT, Cellini M, Mirani M, Lavezzi E, Mazziotti G (2020) Thyrotoxicosis in patients with COVID-19: the THYRCOV study. Eur J Endocrinol 183(4):381–387
Article CAS PubMed PubMed Central Google Scholar
Pizzocaro A, Colombo P, Vena W, Ariano S, Magnoni P, Reggiani F et al (2021) Outcome of Sars-COV-2-related thyrotoxicosis in survivors of Covid-19: a prospective study. Endocrine 73(2):255–260
留言 (0)